METRONOMIC CHEMOTHERAPY

Clinical trials for METRONOMIC CHEMOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new METRONOMIC CHEMOTHERAPY trials appear

Sign up with your email to follow new studies for METRONOMIC CHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug cocktail aims to shrink tough lung cancers

Disease control Not yet recruiting

This phase 2 trial tests whether combining the immunotherapy drug toripalimab with a specific chemotherapy regimen can shrink tumors in people with advanced small cell lung cancer that has progressed after prior treatments. Participants receive toripalimab plus a rotating schedul…

Matched conditions: METRONOMIC CHEMOTHERAPY

Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control

Last updated Jul 15, 2026 00:00 UTC

METRONOMIC CHEMOTHERAPY

Get alerted when new METRONOMIC CHEMOTHERAPY trials appear

New drug cocktail aims to shrink tough lung cancers